qPCR and dPCR Technologies as Complementary Tools in the Development of Cell and Gene Therapies

qPCR and dPCR Technologies as Complementary Tools in the Development of Cell and Gene Therapies

Cell and gene therapies have provided therapeutic benefit to a number of patients and continue to be developed to treat an increasing variety of diseases and conditions. To ensure their safety and efficacy prior to patient use, these therapies must undergo analytical testing that adheres to regulatory standards and guidelines. This webinar will provide a high-level overview of some of the regulatory requirements for cell and gene therapy products and sources of information to guide in their development.

Key takeaways:

• Regulatory overview for cell and gene therapies
• qPCR and dPCR technologies as essential analytical tools
• Successes to guide therapy development

Meet the Expert

Lee Landeen

Executive Director, Pre-clinical Development at Angiocrine Bioscience

Read bio →